http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100523256-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-065 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
filingDate | 2002-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2005-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2005-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100523256-B1 |
titleOfInvention | Novel acid tolerant probiotic lactobacillus acidophilus Probio-40 with probiotic activities |
abstract | The present invention relates to lactic acid bacteria probiotics that are excellent in fixability to intestinal cells and inhibit intestinal cancer cell proliferation and growth of harmful pathogenic microorganisms, and specifically, the microorganism of the present invention, Lactobacillus ashidophilus Probio-40, is an intestinal cell. It has excellent adhesion to cancer, effectively inhibits the growth of intestinal cancer cells and various pathogenic microorganisms with harmful properties, has acid resistance, bile acid and other useful functions, so it can be administered to humans or animals as a substitute for antibiotics, or medicines. It can be used as a formal medicine, health supplements, etc. to stabilize the intestinal microflora, and to treat or prevent the symptoms that may be caused by abnormal fermentation of harmful microorganisms in the intestines such as diarrhea and prevent cancer. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100827318-B1 |
priorityDate | 2002-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.